Αποτελέσματα Αναζήτησης
23 Ιουν 2022 · The majority of thyroid cancer survivors are women (77%), with an incidence more than double that in men. 6 The median age at diagnosis—55 years for males and 50 years for females—is younger than that for most other adult cancers. 11
11 Ιουν 2019 · More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone.
We examined temporal trends and clinical associations with ACT vs. TC use in clinical practice in older women and compared the overall survival of patients receiving adjuvant ACT vs. TC. Methods: We used the SEER-Medicare database for women over 65 diagnosed 2004-2009.
1 Μαΐ 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
The pCR rate was numerically higher with pertuzumab based regimens, including AC-THP (60%; CI 0.56–0.64), TCHP (63%; CI 0.56–0.69), THP (55%; CI 0.50–0.60), as compared with AC-TH (46%; CI 0.41–0.52).
25 Μαΐ 2023 · The following examples show overall survival rates for people with different types of cancer, along with the percentage of those receiving chemotherapy as part of their treatment. The...
1 Μαρ 2006 · Abstract. As the elderly population continues to grow, adjuvant chemotherapy treatment in the elderly is becoming an increasingly important issue for the practicing oncologist.
